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ARSTRACT 
Catheter-related infection (CRI) accounts for a large percentage 
of nosocomial infections, and related bacteremia is a common 
complication. Bacteremia arises in approximately I of 15 
episodes of CR and causes considerable morbidity and occa- 
sional mortality, as well as increased medical costs. The diag- 
nosis of CRI and catheter-related bacteremia (CRB) is still a 
challenge for practitioners treating catheterized patients. Semi- 
quantitative tip culture by the roll-plate method is the corner- 
stone for diagnosis of CRI in routine practice. However, there 
is a great deal of interest in the alternative methods for diag- 
nosing CRI without catheter withdrawal, since treatment of the 
patient can be successfully completed with the infected device 
maintained in place. The conservative management of CRI 
includes perfusion of antibiotics through the infected catheter 
and the antibiotic-lock technique (ALT). Catheter-related infec- 
tion prevention is accomplished mainly by strict adherence to 
hygienic practices in insertion and manipulation of the catheter. 
However, knowledge of the pathophysiology of CRI has led to 
the development of new sophisticated catheters and hubs that 
incorporate mechanical and antibacterial barriers. 
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Infection due to intravascular catheterization is one of 
the leading mechanisms of hospital-acquired infection. 
Catheter-related infection (CFS) accounts for a large per- 
centage of nosocomial infections, and related bacteremia 
is a common complication.’ More than 850,000 episodes 
of CRI are diagnosed yearly in the United States,1,2 and the 
number of episodes of catheter-related bacteremia (CRB) 
is estimated to be higher than 50,000 per year. Without 
doubt, these rates are increasing as more and more 
catheters are used in medical treatments.lm3 
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Catheter-related bacteremia is the third most frequent 
cause of nosocomial bacteremia, with an incidence of 20 
to 30%.” The emergence of CRB is directly related to the 
duration of catheterization and ranges from 0.02 to 0.66 
episodes of bacteremia per 100 days, according to the 
series and the type of catheter used.’ Catheter-related 
bacteremia causes considerable morbidity and occasional 
mortality, as well as high medical costs, derived from diag- 
nosis, treatment, and mainly, prolongation of the patient’s 
in-hospital stay 
The main approach to this problem is prevention. 
This review discusses the diagnosis and treatment of CRB 
and the latest trends in prevention based on the patho- 
physiology of the disease. 
PATHOPHYSIOLOGY OF 
CATHETER-RELATED INFECTIONS 
Catheter-related bacteremia is the final link in a chain of 
events that begins with the simple colonization of a seg- 
ment of the catheter by bacteria or fungi. These micro- 
organisms grow and multiply, favored by local factors that 
interfere with the patient’s immunologic defenses (e.g., 
sheets of fibrin adhering to the catheter walls) and the 
structure and make-up of the catheter itself. Because the 
device is in intimate contact with the systemic circula- 
tion, it is understandable that catheter infection is often 
associated with bacteremia, particularly when the 
catheter is in use. The dissemination of microorganisms 
from the infected catheter through the blood stream can 
provoke a systemic inflammatory response that may give 
rise to a process of severe sepsis and the appearance of 
distant septic metastases. 
Microorganisms colonize the catheter by various 
routes. Migration from the catheter-skin interface over 
the external surface, or from the hub over the internal sur- 
face of the device to the catheter tip are the most com- 
mon.j-7 Other pathways include hematogenous seeding 
from a distant focus of bacteremia (including other 
catheters) and contamination of the infusates.2,8~9 Approx- 
imately 50% of CRIs originate from the skin, 40% from the 
contaminated hub, and 10% from other pathways. This 
distribution reflects duration of catheterization, type of 
catheter used, adherence to preventive measures, and the 
patient population studied.2,10x” 
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MICROORGANISMS Table 1. Methods for the Diagnosis of Catheter-Related Infection 
Coagulase-negative staphylococci and Stapt3yZococcz.u 
aureus are the pathogens most frequently found in CRI. 
They arise from the cutaneous flora of the patient or the 
hands of medical personnel. Gram-negative bacilli are the 
second most common group of pathogens responsible 
for CRI. They are involved in cases acquired in special 
care units and hemodialysis wards, and are common in 
neutropenic patients.‘* Enterobacter spp, Pseudomonas 
cepacia, Stenotrophomona maltophila, and C’itrobacter 
freundii should alert the clinician to check for contami- 
nated infusates, disinfectants, or medical devices other 
than the catheter.13 Fungal etiology is usually related to 
catheters used for parenteral nutrition. Other micro- 
organisms, such as Bacillus lichen@ormis,14 Stomato- 
coccus muciZaginosus,15 Mycobacterium spp,16 and 
Malassezia fury%? l7 also have been implicated in CRI 
cases. 
DIAGNOSIS 
Catheter-related infection should be suspected when 
there is unexplained fever in a catheterized patient. Clin- 
ical suspicion is reinforced if fever can be linked to 
manipulation of the device, or if there are local inflam- 
matory signs. In this situation, the device is usually 
removed and the tip cultured to determine if it is the 
source of the infection. Positive culture dernonstrates 
catheter infection. When blood cultures performed at the 
same time are positive for the same microorganism found 
in the catheter, CRB is diagnosed. In epidemiologic stud- 
ies and studies investigating the pathophysiology of 
catheter infection, molecular typing of catheter and blood 
isolates should be carried out to definitively establish the 
source of bacteremia. 
Catheter culture is the reference method for diag- 
nosing CRI. However, routine catheter withdrawal in case 
of possible CRT implies a rate of between 70 and 80% of 
devices with negative culture that have been unneces- 
sarily removed.r8 For this reason, and because an infected 
catheter does not always have to be withdrawn for treat- 
ment 19-25 alternative methods for diagnosing CRI have 
beenheveloped. Some of the methods used for culturing 
the device, and the strategies that have been developed 
to demonstrate catheter infection without catheter 
removal are listed in Table 1. 
Maki et al were the frost to describe a reliable method 
for microbiologic diagnosis of catheter infecti~on.*” Their 
roll-plate method established a value of 15 colony-form- 
ing units (CFU) as indicative of infection and showed a 
good correlation with CRB episodes. Since this method 
is easy to perform and is reproducible in any laboratory, 
it has become the reference standard for diagnosis of 
CRI. However, the cutoff described (15 CFU) should be 
With catheter withdrawal 
Broth qualitative culture 
Semiquantitative culture (SQC)*” 




Catheter flushing plus SQCB 
Quick methods: Gram and acridine orange stair-P 
Without catheter withdrawal 
Superficial cultures: skin entry site and hub35,36 
Quantitative blood cultures*7s0 
Catheter brushj3 
Quick methods 
Gram stain of superficial cultures34 
Acridine orange leukocyte cytospin tests2 
used only as a guide: differences in the shape, size, and 
materials that make up the catheter, the large variety of 
microorganisms able to adhere to these materials, the 
type of patient catheterized, and the possibility that the 
patient might have received antibiotics for other reasons 
at the time of catheter withdrawal, are all variables that 
can affect this criterion. Since its description in 1977, the 
technique has not been validated according to these vari- 
ables.27 Moreover, the method described by Maki and col- 
leagues cannot detect infections of endoluminal origin, 
since the roll-plate technique investigates only the exter- 
nal surface of the catheter. 
Other quantitative methods evaluate both the exter- 
nal and internal surfaces of the device. Cleri et al, using 
successive flushings of the catheter lumen with culture 
broth, established a value of more than 1000 CFU/mL as 
indicative of catheter infection.28 Brun-Buisson et al 
described a quantitative culture technique simpler to per- 
form than Cleri’s that consists of introducing the seg- 
ment of catheter to be studied in a tube with 1 mL of 
sterile distilled water and agitating.29 Using a cutoff point 
of 10’ CFU/mL, they obtained a sensitivity of 97.5% and 
a specificity of 88% for diagnosing catheter infection, and 
100% sensitivity and specificity for diagnosing CRB. Son- 
ication of the catheter submerged in 10 mL of culture 
broth did not substantially improve the diagnostic per- 
formance of the earlier quantitative techniques30 
The quantitative methods mentioned so far do not 
establish whether a catheter infection is produced by the 
endoluminal, or the exoluminal route. These techniques 
do not differentiate between the two surfaces. In 1985, 
Linares et al described a modification of the quantitative 
method of Cleri that permits this differentiation.G The 
authors rinsed the internal surface of the catheter with 
2 mL of culture medium and then plated serial dilutions 
of 0.1 mL of the medium to quantify endoluminal colo- 
nization. Subsequently, the catheter was cultured accord- 
ing to the technique described by Maki et al to determine 
exoluminal colonization.26 This labor-intensive method 
has a sensitivity of 100% and is of interest in studies con- 
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cerning the pathophysiology of CRL6 Using this tech- 
nique, the same authors demonstrated the importance of 
contamination of the hub in the pathogenesis of CRI.’ 
All the methods so far described require a waiting 
interval of 18 to 24 hours before results are obtained. Sev- 
eral quick techniques, based on microscopic study of with- 
drawn catheters stained by the Gram stain or acridine 
orange methods, have been developed for early diagnosis 
of infected catheters.31,32 The presence of one micro- 
organism per 20 fields observed in the microscope is con- 
sidered to be positive. These rapid methods require 
experienced technicians and are laborious. They are also 
less sensitive and specific. Moreover, they can be performed 
only on transparent plastic catheters with thin walls. 
Swab culture from the skin or the catheter hub, is 
highly predictive that the catheter is not infected when 
results are negative. 33-36 Thus, removal of many catheters 
can be avoided. However, since positive colonization of 
the skin does not ensure that the catheter is the origin 
of sepsis, the positive predictive value of superficial swab 
cultures is lower.36 Gram stain of superficial swabs prior 
to culture permits quick diagnosis of catheter infection 
and can point to its etiology In a preliminary study using 
this rapid technique in patients admitted to the intensive 
care unit with suspected CRB, sensitivity was 77%, speci- 
ficity 86%, positive predictive value 3 1.2%, and negative 
predictive value 97.8%.34 Negative Gram stain from two 
swabs virtually rules out the catheter as the origin of 
infection 24 hours before culture results are available. 
Another method for diagnosis of CRB and for iden- 
tifying an infected catheter without catheter removal 
involves obtaining quantitative blood cultures through 
each catheter placed in the patient, and comparing the 
results with a peripheral blood culture obtained by direct 
venipuncture.37-i0 
Wing et al were the first to propose the usefulness 
of quantitative blood culture in the diagnosis of CRL3’ 
Later works have confirmed this hypothesis in a large 
number of patients and infected catheters.38-51 These stud- 
ies have established that a finding of colony-forming units 
per milliliter of catheter blood that is 4 to 10 times the 
number found in peripheral blood is indicative of CRB. 
The author applied this method during the course of 67 
episodes of fever in catheterized patients (107 devices). 
Seventeen episodes of CR1 were diagnosed, and the 
catheter responsible for the infection was identified in all 
but one of the cases. A differential value higher than or 
equal to four times the number of colony-forming units 
per milliliter between catheter and peripheral blood cul- 
tures diagnosed CRI, and the infected device was identi- 
fied with a sensitivity of 94% and a specificity of 1OO%.49 
More than 100 CFU/mL in a quantitative transcatheter 
blood culture also is highly suggestive of CRI.42,49 Both 
culturing of superficial swabs (skin and hub) and quan- 
titative blood cultures are useful for diagnosing CRB with- 
out catheter withdrawal. Moreover, in a patient with 
several intravascular catheters, quantitative blood cultures 
can determine which one is the origin of sepsis. As an 
additional advantage, quantitative blood cultures obtained 
through the catheter can be used to monitor the effec- 
tiveness of the antibiotic treatment being administered to 
the patient. 
Rushforth et al described a method that results in 
quicker diagnosis of CRB than analyses based on quanti- 
tative blood culture.52 Using acridine orange stain of the 
leukocyte layer obtained by centrifuging blood extracted 
through the catheter, these authors obtained a sensitivity 
of 87% and a specificity of 94% as compared to the cor- 
responding quantitative blood cultures. Detection of bac- 
teria denoted a positive result, and a duplicate cytospin 
preparation was Gram stained to characterize the bacteria. 
Markus and Buday proposed a method using an endo- 
luminal brush to identify an infected central venous 
catheter in situ.53 The brush, composed of plastic bristles 
affixed to a stainless steel wire, collects fibrin as it is 
passed in and out of the device. However, this may be a 
complex and expensive method, and there is still too lit- 
tle experience to recommend its use. 
A recent meta-analysis of diagnostic methods for 
catheter-related bloodstream infection showed that quan- 
titative culture is the most accurate method for catheter 
segment culture, and that unpaired quantitative catheter 
blood culture is the single most cost-effective test, espe- 
cially for long-term catheters.j* 
TREATMENT 
Conventionally, treatment involves simply withdrawing 
the catheter; however, this maneuver raises practical prob- 
lems in central catheters of long duration, in catheters 
that must be implanted and withdrawn in the operating 
room, and in patients with no other vascular access. To 
overcome these problems, several studies have demon- 
strated that these infections may be treated successfully 
without catheter removal, even in immunocompromised 
patients. However, it is advisable to withdraw the catheter 
in cases of septic shock, pulmonary embolism, purulent 
thrombophlebitis, and infection of the subcutaneous tun- 
nel extending more than 2 cm proximally from the 
catheter exit site.11z55 Persistently positive blood cultures 
after 48 hours of appropriate antibiotics should prompt 
catheter removal.j6 
In the majority of cases, catheter withdrawal alone is 
enough to cause fever and symptoms of infection to dis- 
appear. If the patient shows signs of severe sepsis (e.g., 
alterations in general condition, hypotension, shock) or 
when other catheters or prosthetic material (e.g., pace- 
makers, cardiac or joint prostheses) are present, empiri- 
cal antibiotic treatment that covers the majority of 
organisms implicated in catheter sepsis, mainly staphy- 
lococci and gram-negative bacilli, should be initiated. 
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Table 2. Antibiotics Used in Treatment 
of Catheter-Related Sepsis 
Empiric* 
Glycopeptide plus aminoglycoside 
Glycopeptide plus aztreonamt 
According to microbiologic findings 
Cloxacillin* 200 mg/kg/day/lV 
Ampicillin 200 mg/kg/day/lV 
Vancomycin 30 mg/kg/day/lV 
Teicoplanin 6 mg/kg/day/lV 
Aztreonam 3 g/day/IV 
Gentamicin 3 mg/kg/day/lV 
Ciprofloxacin 400-600 mg/day/lV 
Amphotericin B 0.5-I mg/kg/day/lV 
Fluconazole 200-400 mg/day 
*Offering broad antibiotic coverage, including methicillin-resistant staphylococci 
and gram-negative bacilli. 
+Especially indicated in patients with renal insufficiency. 
*Or other penicillinase-resistant penicillins. 
Treatment will vary in each hospital according to the rate 
of methicillin resistance and the spectrum of gram-neg- 
ative bacilli causing the catheter sepsis. Table 2 lists some 
of the antibiotics that can be used. In each specific case, 
the duration of antibiotic treatment for catheter sepsis 
depends on the intensity of the initial bacteremia, the 
clinical condition of the patient, possible metastatic com- 
plications, and the microorganism responsible. In gen- 
eral, antibiotic treatment is administered for 7 to 15 days. 
In infections by S. aureus or Streptococcus faecalis, treat- 
ment is prolonged for 15 days, to avoid the alppearance 
of late-emerging septic metastases, mainly endocarditis 
and osteomyelitis. 57 In Candida spp infections ampho- 
tericin B should be administered until an accumulated 
dose of 300 to 500 mg is reached. Fluconazole is a good 
alternative for treating candidiasis due to susceptible 
species.j8 Other noncandidal yeast catheter infections 
could be appropriately treated by a combination of 
amphotericin B and catheter removal, although catheter 
withdrawal is not always mandatory.17,j9 Data. from the 
Sloan-Kettering Memorial Cancer Center (NewYork) sug- 
gest that catheter removal is not always necessary for a 
favorable outcome of candidemia.60 In a prospective ran- 
domized study conducted by Anaissie et al, removal of 
central venous catheters from patients with candidemia 
did not improve outcome. 61 In an in vitro study, a higher 
concentration of liposomal amphotericin B than ampho- 
tericin B was required to produce a similar effect in 
reducing the number of yeasts adhering to the surface of 
plastic catheters.@ Infection due to ffiamentous fungi aris- 
ing in neutropenic patients should prompt catheter 
removal.‘1~63 When there is purulent thrombophlebitis, 
surgical resection of the affected vein and heparinization 
can be considered.64 
Treatment of catheter-related sepsis (CRS) while 
maintaining the catheter in place involves sterilizing the 
catheter and treating the sepsis. Several strategies have 
been designed to achieve this, always adapted to the par- 
ticular situation of each patient; that is, taking into 
account the number and type of catheters in place and 
their purpose. Sepsis should be treated by systemic 
administration of antibiotics through the infected route 
or a separate route, while the infected catheter is sub- 
jected to continuous perfusion of antibiotics or the antibi- 
otic-lock technique (AIT). The ALT consists of filling and 
closing the catheter lumen with an antibiotic solution 
that acts locally, sterilizing the device. With this method, 
a high continuous local concentration of antibiotic may 
be applied and systemic toxicity and the need to moni- 
tor serum drug levels can be avoided.65 Moreover, since 
the catheter is closed, there is no chance of distant dis- 
semination of microorganisms, as may occur with con- 
tinuous perfusion. The ALT in association with systemic 
administration of antibiotics at the end of each dialysis 
obviated catheter withdrawal in a series of patients in 
end-stage renal failure. 22 This strategy was cost-effective 
and was not associated with long-term infectious com- 
plications. 66 In other settings, such as in pediatric 
patients,67 ambulatory parenteral nutrition,23 or acquired 
immunodeficiency syndrome (AIDS),25 the ALT with or 
without concomitant administration of systemic anti- 
biotics has proven to be efficacious without catheter 
removal. Some authors administered systemic antibiotics 
during the first 2 or 3 days and subsequently use only the 
ALTz3J5 This depends on the clinical setting and patient 
condition. Many questions remain to be resolved, includ- 
ing appropriate concentration of intracatheter antibiotics, 
duration of the ALT, and the role of heparin-lock in asso- 
ciation with antibiotics. 
Totally implanted venous access devices and subcu- 
taneous ports also can be treated locally without removal. 
However, the comparative success of treating these infec- 
tions in situ is lower, mainly if the pocket is infected.51 
PREVENTION 
Catheter-related infection is a preventable nosocomial 
infection. Published guidelines have promoted practices 
aimed at the prevention of CRLG8 Of these, certain easy- 
to-perform rules for hygiene have proven effective. The 
use of sterile barriers during catheter insertion is of 
utmost importance for avoiding early CRI. This involves 
wearing sterile gloves, a mask, a gown, and a cap, and 
using a large drape during insertion of a central venous 
catheter (CVC). The patient’s skin should be carefully dis- 
infected.69 In centers with high rates of CRI, teams of 
health care workers trained in catheter insertion and 
maintenance could be cost-effective. Peripherally inserted 
CVCs are less prone to be infected than centrally 
implanted ones. ‘O Subclavian catheters have a lower rate 
of infection than jugular or femoral catheters. Multilumen 
catheters are more susceptible to infection than mono- 
lumen catheters, probably because they are subject to 
more manipulation.71 
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There is some controversy about the type of dress- 
ing at the catheter exit site. Changing the infttsate tubing 
and dressing at the insertion site every 24 hours is no 
more protective than changing them every 72 hours.72,73 
Periodic catheter removal is not sustained in terms of 
prevention of catheter infection and involves additional 
risks and cost. Central venous catheter exchange over a 
guide wire may protect against the mechanical compli- 
cations of catheter insertion but it does not avoid colo- 
nization of the new catheter and could increase the risk 
for bloodstream infection.‘* 
Subcutaneous tunnelling of the catheter has been 
used to make exoluminal colonization more difficult. Use 
of this strategy alone fails in prolonged catheterization, 
where infection is produced mainly by the endoluminal 
route.75 The use of a silver-impregnated subcutaneous 
collagen cuff provides both an antimicrobial and a 
mechanical barrier to microorganism migration from the 
skin. Again, this is protective in catheters of short-term 
use, but fails with long-term central venous catheters.76,77 
Since initial colonization of the hub is an important 
event in the pathogenesis of CRS, a new hub model has 
been designed to protect against hub colonization.‘* The 
model has a female component that consists of a plastic 
cylinder, with latex rubber closures at both ends, which 
limits a chamber containing 0.2 mL of 3% iodinated alco- 
hol. The male component is a 18- to 20-gauge needle that 
connects to the female component on one side and 
attaches to the infusion tube on the other side. When 
the two portions are connected, the needle passes 
through the antiseptic chamber and is sterilized by con- 
tact with the antiseptic solution. This new hub model 
reduced CRS fourfold in a population of patients with 
long-term CVCs for parenteral nutrition.79 Trials assess- 
ing its efficacy in terms of cost benefits are on-going. 
Coating catheters with antimicrobial agents that are 
released on both the internal and external surfaces, is fea- 
sible for preventing CRI. Several promising studies using 
antibiotic-impregnated catheters have shown the efficacy 
of this method.80-84 The antimicrobial coated on the 
catheter has to provide broad-spectrum antibacterial 
activity and remain stable for a long period of time. 
Recently, two works have provided additional evidence 
to support the clinical applicability of antiseptic or anti- 
microbial coating of catheters. Use of central venous 
catheters coated with chlorhexidine-silver sulfadiazine 
was associated with a 44% reduction in catheter colo- 
nization and a 79% reduction in the rate of CRB.83 Use of 
CVCs coated with minocycline and rifampin was also 
associated with significant reductions in the rates of 
catheter colonization and CRB compared with noncoated 
catheters.** The beneficial effects of these catheters were 
more evident in the first 10 days of catheter use. These 
two studies did not report adverse events related to 
impregnated catheters. It seems clear that impregnated 
catheters decrease overall rates of infection and, in turn, 
reduce cost. However, more experience is needed in var- 
ious clinical circumstances and in each particular insti- 
tution before use of impregnated catheters can be 
generally recommended. 
A more economic approach is to periodically flush 
the catheter with an antibiotic solution.85 This preven- 
tive measure is useful in settings with a high rate of CRI 
caused by the same microorganism. There is some con- 
cern about the potential emergence of resistant micro- 
organisms when antimicrobial agents are used to prevent 
CRI, and isolates obtained from catheterized patients 
should be strictly monitored. 
Catheter infection is still an important cause of noso- 
comial infection. From the cost-benefit point of view it 
is important to adopt appropriate measures for hygiene 
during insertion and manipulation of these devices and 
to consider diagnosis and treatment of CRB without 
catheter withdrawal. 
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